Cannell & Spears’s Inspire Medical Systems INSP Stock Holding History

Cannell & Spears’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,610	Closed	-$982K	–	244
2020 Q3	$982K	Buy	+7,610	New	+$839K	0.09%	87

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Cannell & Spears's INSP Position: Q4 2020 in Review

Cannell & Spears sold out of Inspire Medical Systems (INSP) in Q4 2020, closing a stake of 7,610 shares — an estimated $982K sold.

Cannell & Spears first reported a position in INSP in Q3 2020 and held it in 1 quarter. The position peaked at $982K in Q3 2020. 239 funds tracked by Wall St. Rank hold INSP as of Q4 2020.

Cannell & Spears reported no remaining Inspire Medical Systems position as of Q4 2020 after selling out during the quarter.
Cannell & Spears sold 7,610 Inspire Medical Systems shares in Q4 2020, an estimated $982K.
Cannell & Spears first reported a position in Inspire Medical Systems in Q3 2020 and held it in 1 quarter.
Cannell & Spears's Inspire Medical Systems position peaked at $982K in Q3 2020.
239 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2020.

Based on Cannell & Spears's 13F filing for Q4 2020, filed 12 Feb 2021.